Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial.

DJ Jamieson, CS Chasela, MG Hudgens, CC King, AP Kourtis, D Kayira, MC Hosseinipour, DD Kamwendo, SR Ellington, JB Wiener, SA Fiscus, G Tegha, IA Mofolo, DS Sichali, LS Adair, RJ Knight, F Martinson, Z Kacheche, A Soko, I Hoffmander Horst C Van, BAN Study Team

Research output: Contribution to journalArticle

63 Scopus citations
Original languageEnglish (US)
Pages (from-to)2449-2458
Number of pages10
JournalLancet
Volume379
Issue number9835
StatePublished - Jun 2012

Cite this

Jamieson, DJ., Chasela, CS., Hudgens, MG., King, CC., Kourtis, AP., Kayira, D., Hosseinipour, MC., Kamwendo, DD., Ellington, SR., Wiener, JB., Fiscus, SA., Tegha, G., Mofolo, IA., Sichali, DS., Adair, LS., Knight, RJ., Martinson, F., Kacheche, Z., Soko, A., ... Team, BAN. S. (2012). Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial. Lancet, 379(9835), 2449-2458.